The
market for anti-hypertensive drugs in Egypt is expected to expand at an
incredible pace between 2024 and 2028. Many people across the world suffer with
hypertension, also known as high blood pressure. A significant percentage of
the population in Egypt suffers from hypertension, which is an important
contributor to heart attacks and strokes as well as other cardiovascular
conditions. The market for anti-hypertensive drugs has expanded as a result of
unhealthy lifestyle choices such as smoking, improper eating, and a lack of
physical activity.
Generic
anti-hypertensive drugs are becoming more widely available in Egypt, making it
simpler and more economical for patients to get their medications. As a result,
there is a greater need for anti-hypertensive drugs, which has helped the
market grow.
New
and more effective anti-hypertensive drugs have been created as a result of
advances in technology in the field of medicines. Due to the rise in the demand
for more advanced as well as effective treatments, the availability of these
drugs has helped the market expand.
Patients
from all over the world seeking to take advantage of affordable healthcare
services visit Egypt, which continues to be an important destination for
medical tourism. The availability of anti-hypertensive drugs and other
medications has led to the expansion of the
medical tourism sector in Egypt, which has supported the market to grow.
Increased
access to health insurance in Egypt has rendered it simpler for patients to
obtain healthcare services, such as anti-hypertensive drugs. As a result, there
is more demand for these drugs, which has helped the market grow.
The
Egyptian government has been spending more on healthcare lately which has
helped the market expansion. Spending higher amounts has ended up resulting in
new healthcare facilities being developed, more people having access to
healthcare services, and more people needing anti-hypertensive drugs.
According
to an article titled “A semi-systematic review on hypertension and dyslipidemia
care in Egypt—highlighting evidence gaps and recommendations for better patient
outcomes”, the prevalence of hypertension in Egypt ranged from 12.1 to 59%.
Many
barriers hinder the growth of the market for anti-hypertensive drugs in Egypt. Factors
such as the high cost of medications, low awareness of hypertension, inadequate
healthcare infrastructure, lenient regulatory framework, lack of qualified
professionals, resistance to change, insufficient funding, insufficient insurance
coverage, dependence on imports, and lack of proper monitoring are a few
challenges that may hinder the growth of the Egypt anti-hypertensive drugs.
Egypt's
inadequate healthcare system has an impact on the market expansion for
anti-hypertensive medications. There is a lack of medical staff, supplies, and
facilities, which leads to substandard healthcare services, especially the
accessibility of anti-hypertensive medications.
The
healthcare industry in Egypt has a shortage in skilled professionals. This has
an impact on the quality of healthcare services and the expansion of the market
for anti-hypertensive drugs. Many healthcare providers lack the abilities and
information necessary to correctly identify and manage hypertension.
Despite
the availability of generic anti-hypertensive drugs, the cost of medication is
still a major barrier for many people in Egypt. The high cost of treatment can
prevent patients from accessing the medication they need, resulting in
untreated or poorly managed hypertension. This affordability issue is
especially challenging for those without health insurance or those living in
rural areas where access to healthcare services is limited.
The
Egyptian government has been placing a growing emphasis on prevention and early
detection of hypertension. This includes initiatives such as public awareness
campaigns, screening programs, and training programs for healthcare
professionals. By promoting prevention and early detection, the government aims
to reduce the burden of hypertension and its associated complications. This
focus on prevention and early detection is expected to drive the demand for
anti-hypertensive drugs, which, in turn, will support the growth of the market
in the coming years.
Combination
therapies, which involve the use of two or more drugs to manage hypertension,
are becoming increasingly popular in Egypt. Combination therapies are often
more effective than single-drug therapies and can help patients achieve their
blood pressure goals more quickly. The increasing use of combination therapies
is expected to drive the demand for anti-hypertensive drugs, which, in turn,
will support the growth of the market in the coming years.
Telemedicine,
which involves the use of remote communication technologies to provide
healthcare services, is becoming increasingly popular in Egypt. Telemedicine
can help overcome the challenges of inadequate healthcare infrastructure and
shortages of healthcare professionals, particularly in rural areas. The
increasing adoption of telemedicine is expected to increase access to
healthcare services, which, in turn, will drive the demand for
anti-hypertensive drugs in the coming years.
Download Free Sample Report
Rising
Prevalence of Hypertension
The
growing prevalence of hypertension in Egypt can be attributed to several
factors, including an aging population, changing dietary patterns, and
sedentary lifestyles. As the population continues to age and adopt unhealthy
lifestyles, the prevalence of hypertension is expected to increase further.
This has led to a growing demand for antihypertensive drugs in Egypt, which is
expected to drive the growth of the market in the coming years.
Antihypertensive
drugs work by reducing blood pressure and preventing damage to the organs that
can be caused by high blood pressure. There are several classes of
antihypertensive drugs available in Egypt, including diuretics, beta-blockers,
ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers.
These drugs are often used in combination to achieve blood pressure control.
The
growing prevalence of hypertension in Egypt has led to an increased demand for
antihypertensive drugs, which, in turn, has increased the availability and
affordability of these drugs. As the market for antihypertensive drugs in Egypt
continues to grow, there has been a focus on improving access to these drugs,
particularly in rural areas.
Technological
Advancements
Technological
advancements have a significant impact on the growth of the Egypt anti-hypertensive
drugs market. These advancements have enabled the development of new drugs,
improved drug delivery methods, and enhanced patient monitoring and management
systems, among other things. As a result, technological advancements have
facilitated the growth of the Egypt anti-hypertensive drugs market in several
ways.
The
use of technology has also enabled the development of more effective drug
delivery methods. For example, advances in nanotechnology have enabled the
development of nanocarriers, which can be used to deliver drugs directly to
target cells or tissues. This approach can improve drug efficacy while reducing
side effects.
In
addition to drug development and delivery, technological advancements have
facilitated the development of patient monitoring and management systems.
Wearable devices, such as smartwatches and fitness trackers, can monitor blood
pressure and other vital signs and provide real-time feedback to patients and
healthcare providers. This can help patients to better manage their
hypertension and can enable healthcare providers to provide more personalized
and effective care.
Advancements
in telemedicine and remote monitoring technologies have enabled patients in
remote or underserved areas to receive medical care for hypertension. This has
helped to improve access to care and to reduce the burden of hypertension on
the healthcare system.
Introduction
of Telemedicine
Telemedicine
has the potential to revolutionize the way that healthcare is delivered in
Egypt, and this is particularly true for the treatment of hypertension. As
telemedicine continues to grow and become more widely adopted, it is expected
to have a significant impact on the growth of the anti-hypertensive drugs
market in Egypt.
Telemedicine
can also help to improve medication adherence among patients with hypertension.
Studies have shown that patients who receive remote monitoring and support are
more likely to take their medications as prescribed and to make lifestyle
changes that can help to control their hypertension. This can lead to better
health outcomes and a reduced risk of complications associated with
hypertension.
Telemedicine
can improve patient education and support. Patients with hypertension often
require ongoing education and support to manage their condition effectively.
Telemedicine platforms can provide patients with access to educational
materials, medication reminders, and personalized coaching, among other things.
This can help to improve medication adherence and to reduce the risk of complications
associated with hypertension.
Market Segmentation
The
Egypt anti-hypertensive drugs market can be segmented by therapeutic
class, type,
distribution channel, and region. By therapeutic class, the Egypt
anti-hypertensive drugs market can be segmented into diuretics, ACE inhibitors,
angiotensin receptor blockers (ARBs), calcium channel blockers, beta adrenergic
blockers, renin inhibitors, vasodilators, and others. Based on type, the Egypt anti-hypertensive
drugs market is further segmented into primary hypertension and secondary
hypertension. Based on distribution channel, the Egypt anti-hypertensive drugs
market is further segmented into retail pharmacy, hospital pharmacy, and e-commerce
websites & online drug stores.
Market Players
Amoun Pharmaceutical Company,
EIPICO (Egyptian International Pharmaceutical Industries Co.), Delta Pharma, Rameda
Pharmaceutical Company, El-Nasr Pharmaceutical Chemicals Company, and Egyphar are
some of the leading
companies operating in the market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2022
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million, Volume Units and
CAGR for 2018-2022 and 2023-2028
|
|
Report coverage
|
Revenue forecast, Volume forecast company share, competitive
landscape, growth factors, and trends
|
|
Segments covered
|
By Therapeutic Class
By Type
By Distribution Channel
By Region
|
|
Regional scope
|
Cairo; Qalyubia; Alexandria;
Port Said; Giza; Suez
|
|
Key companies profiled
|
Amoun Pharmaceutical Company, EIPICO
(Egyptian International Pharmaceutical Industries Co.), Delta Pharma, Rameda
Pharmaceutical Company, El-Nasr Pharmaceutical Chemicals Company, and Egyphar
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet
your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, the Egypt anti-hypertensive drugs market has been
segmented into following categories, in addition to the industry trends which
have also been detailed below:
·
Egypt
Anti-Hypertensive Drugs Market, By Therapeutic Class
o
Diuretics
o
ACE inhibitors
o
Angiotensin Receptor Blockers (ARBs)
o
Calcium Channel Blockers
o
Beta Adrenergic Blockers
o
Renin Inhibitors
o
Vasodilators
o
Others
·
Egypt Anti-Hypertensive Drugs Market, By Type
o
Primary Hypertension
o
Secondary Hypertension
·
Egypt Anti-Hypertensive Drugs Market, By Distribution Channel
o
Retail Pharmacy
o
Hospital Pharmacy
o
E-commerce Websites & Online Drug Stores
·
Egypt
Hospital Bed Market,
By Region
o
Cairo
o
Alexandria
o
Giza Qalyubia
o
Port Said Suez
o
Rest of Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present in the Egypt anti-hypertensive drugs market
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Egypt Anti-Hypertensive Drugs Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]